Example: Heart Attack

Search clinical trials for: Hemagglutinins

Total 143 results

NCT04451954

Recruiting

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Conditions: Influenza
NCT04363359

Not yet recruiting

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Conditions: Influenza
NCT04144179

Completed

Recombinant Influenza Vaccine Containing Different H3 Antigens in Healthy Adults 18 to 30 Years of Age

Conditions: Influenza
NCT04143451

Recruiting

Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients

Conditions: Influenza
NCT04077424

Completed

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Conditions: Flu Vaccine
NCT04024228

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Conditions: Influenza (Healthy Volunteers)
NCT04001504

Recruiting

Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes

Conditions: Acute Coronary Syndrome
NCT03755427

Not yet recruiting

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Conditions: H7N9 Influenza
NCT03751514

Recruiting

Bordetella Pertussis Colonisation Challenge Study

Conditions: Whooping Cough
NCT03738241

Completed

2017 A/H7N9 IIV Revaccination

Conditions: Avian Influenza; Influenza Immunisation
NCT03694392

Recruiting

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Conditions: Influenza; Pneumonia; Lower Respiratory Tract Infection; Acute Myocardial Infarction; Congestive Heart Failure; Stroke
NCT03598439

Active, not recruiting

Randomized Influenza Vaccine Evaluation of Immune Response

Conditions: Influenza
NCT03569098

Completed

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Conditions: Hallux Abductovalgus
NCT03472976

Completed

H5N1 With or Without Topical Aldara in Healthy Adults

Conditions: Avian Influenza; Influenza Immunisation
NCT03460743

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Conditions: Influenza, Human
NCT03448705

Unknown status

Safety of 4Fluart Intradermal Suspension for Injection (Influenza Vaccine, Whole-virion, Inactivated, Adjuvanted) in Adult Subjects

Conditions: Influenza
NCT03438487

Active, not recruiting

Flucelvax (TIVc or QIVc) Pregnancy Registry

Conditions: Influenza, Human; Pregnancy; Birth Defect
NCT03369808

Unknown status

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Conditions: H7N9 Influenza
NCT03330132

Active, not recruiting

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong

Conditions: Influenza, Human
NCT03300050

Completed

Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine

Conditions: Influenza; Vaccine
NCT03095599

Completed

Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3

Conditions: Influenza, Human
NCT03068949

Recruiting

Comparison of Three Licensed Influenza Vaccines

Conditions: Influenza
NCT03038776

Completed

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Conditions: Influenza, Avian
NCT02998996

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Conditions: Influenza, Human
NCT02988739

Completed

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Conditions: Influenza in Human
NCT02955030

Completed

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

Conditions: Influenza
NCT02935192

Completed

Phase 3 Trial of Serbian Seasonal Influenza Vaccine

Conditions: Influenza
NCT02921997

Completed

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Conditions: Avian Influenza; H1N1 Influenza; Influenza
NCT02914275

Completed

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

Conditions: Influenza, Human
NCT02876159

Completed

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination

Conditions: Influenza
NCT02839330

Completed

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Conditions: Avian Influenza
NCT02713061

Withdrawn

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Conditions: Influenza Prevention
NCT02680002

Completed

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

Conditions: A/Vietnam/H5N1 Influenza Virus
NCT02660138

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

Conditions: Urinary Incontinence; Overactive Bladder
NCT02660359

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Conditions: Urinary Incontinence; Overactive Bladder
NCT02600585

Completed

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Conditions: Human Influenza
NCT02555618

Completed

Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants

Conditions: Influenza Infection
NCT02545543

Completed

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

Conditions: Influenza, Human
NCT02511002

Recruiting

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Conditions: Post Influenza
NCT02500680

Active, not recruiting

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

Conditions: Influenza, Human
NCT02493946

Completed

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Conditions: Glabellar Lines
NCT02464163

Completed

Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older

Conditions: Influenza
NCT02434276

Unknown status

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Conditions: Influenza
NCT02415842

Completed

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Conditions: Immunologic Tests
NCT02381418

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Conditions: Influenza
NCT02335164

Completed

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Conditions: Influenza
NCT02290509

Completed

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Conditions: Influenza
NCT02285998

Completed

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Conditions: Influenza
NCT02263040

Completed

A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV

Conditions: Influenza
NCT02247362

Unknown status

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Conditions: Influenza

Search clinical trials for: Hemagglutinins

Recent CRA jobs

Start-up CRA, Ukraine

Remote Site Monitor, Ukraine

Accounting Coordinator (Cambridge)

Associate Treasury Analyst (Cambridge)

Sr Safety Reporting Admin

Recruitment Coordinator (6-month)

CRA (Level I or II)

Clinical Trial Coord (Previuos called PA)

CRA (Level to be defined)

Assoc Biostatistician- Wayne PA